CJC-1295 with DAC tracker
Educational reference for CJC-1295 with DAC. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
168 h
Tmax
72 h
Category
peptide
> PLACEHOLDER — pending clinical review by licensed pharmacist. CJC-1295 with DAC incorporates a drug affinity complex that covalently attaches to albumin, extending its plasma half-life to approximately 7 days. This modification allows once-weekly dosing while maintaining continuous GHRH receptor stimulation. The DAC form produces sustained GH pulse amplification over days, which differs significantly from the pulsatile profile of non-DAC GHRH analogues. The extended half-life means longer washout periods if side effects occur. Systematic tracking of GH-related symptoms, injection site reactions, and concomitant compound timing is particularly important for this long-acting peptide.
Mechanism
A GHRH analog bearing a drug-affinity complex (DAC) that binds albumin to substantially extend its half-life. Like other GHRH analogs, it stimulates the GHRH receptor to promote growth-hormone release.
Research summary
Studied as a long-acting GHRH analog in early clinical pharmacology work. It is not an FDA-approved therapeutic, and long-term human outcome data are limited.
Dosing in the literature
Early pharmacology studies used subcutaneous administration under research conditions; the DAC extends duration relative to non-DAC variants. No approved regimen exists and this summary does not provide dosing.
Reported side effects
Reported effects include injection-site reactions, flushing, and headache. Sustained elevation of growth hormone and IGF-1 is a monitoring consideration in a clinical context. The full profile is not established.
Stacking notes
Frequently discussed with a ghrelin-receptor secretagogue such as ipamorelin in the literature; any combination is a clinical/experimental decision.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- CJC-1295 with DAC pharmacology study · Journal of Clinical Endocrinology & Metabolism (2006)search PubMed for CJC-1295 DAC growth hormone
- GHRH analog reviews · peer-reviewed review articles (2015)class context
References
- CJC-1295 with DAC PK studyDOI: 10.1210/jc.2005-1536
Track CJC-1295 with DAC in TrackPep
Reconstitution calculator, interactive body-map rotation, side-effect timeline, weight trends, and a private log — all in one place. Free to try.